Salli Fennessey

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

Vaishali Sanchorawala, Daniel G. Wright, Michael Rosenzweig et al. · Blood · 2006 · 258 citations · Full text

Tolerability and Efficacy of Thalidomide for the Treatment of Patients with Light Chain–Associated (AL) Amyloidosis

David C. Seldin, Élie Choufani, Laura M. Dember et al. · Clinical Lymphoma · 2003 · 146 citations

Medicine, Pharmacology, Light Chain–associated +1

Kidney dysfunction during lenalidomide treatment for AL amyloidosis

R. Specter, Vaishali Sanchorawala, David C. Seldin et al. · Nephrology Dialysis Transplantation · 2010 · 112 citations · Full text

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis

Ümit Tapan, David C. Seldin, Kathleen T. Finn et al. · Blood · 2010 · 74 citations · Full text

Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115

Vaishali Sanchorawala, Antje Hoering, David C. Seldin et al. · Bone Marrow Transplantation · 2013 · 23 citations · Full text

Translational Medicine, Al Amyloidosis, Clinical Trials +4